1. Home
  2. CTKB vs IRMD Comparison

CTKB vs IRMD Comparison

Compare CTKB & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • IRMD
  • Stock Information
  • Founded
  • CTKB 1990
  • IRMD 1992
  • Country
  • CTKB United States
  • IRMD United States
  • Employees
  • CTKB N/A
  • IRMD N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • IRMD Medical/Dental Instruments
  • Sector
  • CTKB Health Care
  • IRMD Health Care
  • Exchange
  • CTKB Nasdaq
  • IRMD Nasdaq
  • Market Cap
  • CTKB 718.8M
  • IRMD 668.2M
  • IPO Year
  • CTKB 2021
  • IRMD 2014
  • Fundamental
  • Price
  • CTKB $2.83
  • IRMD $57.79
  • Analyst Decision
  • CTKB Hold
  • IRMD Strong Buy
  • Analyst Count
  • CTKB 4
  • IRMD 1
  • Target Price
  • CTKB $6.00
  • IRMD $72.00
  • AVG Volume (30 Days)
  • CTKB 1.1M
  • IRMD 36.2K
  • Earning Date
  • CTKB 05-08-2025
  • IRMD 07-31-2025
  • Dividend Yield
  • CTKB N/A
  • IRMD 1.17%
  • EPS Growth
  • CTKB N/A
  • IRMD 10.72
  • EPS
  • CTKB N/A
  • IRMD 1.55
  • Revenue
  • CTKB $197,050,000.00
  • IRMD $75,154,639.00
  • Revenue This Year
  • CTKB $3.25
  • IRMD $10.62
  • Revenue Next Year
  • CTKB $8.58
  • IRMD $9.69
  • P/E Ratio
  • CTKB N/A
  • IRMD $37.46
  • Revenue Growth
  • CTKB N/A
  • IRMD 11.04
  • 52 Week Low
  • CTKB $2.37
  • IRMD $41.69
  • 52 Week High
  • CTKB $7.63
  • IRMD $63.29
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 43.14
  • IRMD 64.35
  • Support Level
  • CTKB $2.37
  • IRMD $50.88
  • Resistance Level
  • CTKB $2.61
  • IRMD $59.05
  • Average True Range (ATR)
  • CTKB 0.18
  • IRMD 1.93
  • MACD
  • CTKB 0.04
  • IRMD 0.57
  • Stochastic Oscillator
  • CTKB 63.45
  • IRMD 84.58

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: